Notis-McConarty Edward’s Bristol-Myers Squibb BMY Stock Holding History

Notis-McConarty Edward’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,235	Closed	-$323K	–	80
2024 Q3	$323K	Sell	6,235 -3,100	-33%	-$145K	0.15%	69
2024 Q2	$388K	Sell	9,335 -800	-8%	-$35.8K	0.15%	70
2024 Q1	$550K	Sell	10,135 -3,375	-25%	-$172K	0.22%	66
2023 Q4	$693K	Sell	13,510 -6,915	-34%	-$363K	0.28%	61
2023 Q3	$1.19M	Sell	20,425 -1,100	-5%	-$67.4K	0.48%	50
2023 Q2	$1.38M	Hold	21,525	–	–	0.52%	48
2023 Q1	$1.49M	Hold	21,525	–	–	0.59%	44
2022 Q4	$1.55M	Sell	21,525 -800	-4%	-$60.3K	0.64%	42
2022 Q3	$1.59M	Sell	22,325 -75	-0.3%	-$5.44K	0.71%	40
2022 Q2	$1.73M	Hold	22,400	–	–	0.72%	44
2022 Q1	$1.64M	Hold	22,400	–	–	0.58%	47
2021 Q4	$1.4M	Hold	22,400	–	–	0.47%	58
2021 Q3	$1.33M	Buy	22,400 +550	+3%	+$36.2K	0.49%	58
2021 Q2	$1.46M	Hold	21,850	–	–	0.54%	53
2021 Q1	$1.38M	Buy	21,850 +750	+4%	+$46.7K	0.54%	56
2020 Q4	$1.31M	Sell	21,100 -750	-3%	-$46.1K	0.53%	57
2020 Q3	$1.32M	Sell	21,850 -995	-4%	-$59.9K	0.58%	51
2020 Q2	$1.34M	Sell	22,845 -920	-4%	-$55K	0.63%	49
2020 Q1	$1.32M	Sell	23,765 -100	-0.4%	-$6.11K	0.73%	46
2019 Q4	$1.53M	Buy	23,865 +3,670	+18%	+$210K	0.68%	44
2019 Q3	$1.02M	Sell	20,195 -166	-0.8%	-$7.8K	0.48%	57
2019 Q2	$924K	Sell	20,361 -525	-3%	-$24.5K	0.44%	60
2019 Q1	$997K	Sell	20,886 -600	-3%	-$29.9K	0.48%	54
2018 Q4	$1.12M	Sell	21,486 -25	-0.1%	-$1.34K	0.62%	48
2018 Q3	$1.33M	Hold	21,511	–	–	0.71%	42
2018 Q2	$1.19M	Hold	21,511	–	–	0.71%	44
2018 Q1	$1.36M	Sell	21,511 -200	-0.9%	-$12.9K	0.82%	38
2017 Q4	$1.33M	Buy	21,711 +6,550	+43%	+$410K	0.76%	42
2017 Q3	$966K	Hold	15,161	–	–	0.61%	52
2017 Q2	$844K	Hold	15,161	–	–	0.55%	54
2017 Q1	$824K	Sell	15,161 -250	-2%	-$13.7K	0.54%	56
2016 Q4	$901K	Hold	15,411	–	–	0.62%	51
2016 Q3	$831K	Buy	15,411 +100	+0.7%	+$6.42K	0.57%	56
2016 Q2	$1.13M	Hold	15,311	–	–	0.79%	43
2016 Q1	$978K	Hold	15,311	–	–	0.69%	48
2015 Q4	$1.05M	Sell	15,311 -400	-3%	-$26.4K	0.76%	45
2015 Q3	$930K	Buy	15,711 +66	+0.4%	+$4.19K	0.7%	45
2015 Q2	$1.04M	Hold	15,645	–	–	0.7%	45
2015 Q1	$1.01M	Hold	15,645	–	–	0.7%	44
2014 Q4	$924K	Hold	15,645	–	–	0.63%	48
2014 Q3	$800K	Hold	15,645	–	–	0.56%	54
2014 Q2	$759K	Hold	15,645	–	–	0.5%	59
2014 Q1	$813K	Sell	15,645 -400	-2%	-$21.3K	0.57%	55
2013 Q4	$853K	Buy	+16,045	New	+$817K	0.6%	53

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Notis-McConarty Edward's BMY Position: Q4 2024 in Review

Notis-McConarty Edward sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 6,235 shares — an estimated $323K sold.

Notis-McConarty Edward first reported a position in BMY in Q4 2013 and held it in 44 quarters. The position peaked at $1.73M in Q2 2022. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

Notis-McConarty Edward reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
Notis-McConarty Edward sold 6,235 Bristol-Myers Squibb shares in Q4 2024, an estimated $323K.
Notis-McConarty Edward first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 44 quarters.
Notis-McConarty Edward's Bristol-Myers Squibb position peaked at $1.73M in Q2 2022.
2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Notis-McConarty Edward's 13F filing for Q4 2024, filed 13 Feb 2025.